Physician

Brian Christopher Thomas, MD

According to 2025 Medicare claims, Brian Thomas, MD (NPI: 1508837394) practices dermatology in the Florence-Muscle Shoals, AL market, with the plurality of this provider's patient population coming from Lauderdale, AL. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1346855327; TIN: 391351587) and primary practice location at 35630-1067.

Thomas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,394 traditional Medicare patients, billed 6,978 HCPCS/CPT codes, and received $409,914 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,749 prescription claims across 1,034 beneficiaries totaling $1,889,702 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 8 records totaling $150. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $231,240 to $1,889,702. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$269K$538K2015 Medicare payment: $460,834 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $493,581 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $438,729 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $515,906 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $538,227 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $455,425 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $428,703 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $417,155 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $408,134 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $409,914 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,86512,108$460,834
20162,90013,113$493,581
20172,68111,772$438,729
20182,79311,951$515,906
20192,99212,105$538,227
20202,5209,668$455,425
20211,4127,317$428,703
20221,4177,585$417,155
20231,4427,573$408,134
20241,3946,978$409,914

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$945K$1.9M2015 Drug cost: $231,240 (USD; Tot_Drug_Cst)2016 Drug cost: $302,805 (USD; Tot_Drug_Cst)2017 Drug cost: $396,001 (USD; Tot_Drug_Cst)2018 Drug cost: $375,081 (USD; Tot_Drug_Cst)2019 Drug cost: $632,261 (USD; Tot_Drug_Cst)2020 Drug cost: $743,643 (USD; Tot_Drug_Cst)2021 Drug cost: $950,207 (USD; Tot_Drug_Cst)2022 Drug cost: $1,120,351 (USD; Tot_Drug_Cst)2023 Drug cost: $1,564,774 (USD; Tot_Drug_Cst)2024 Drug cost: $1,889,702 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156502,061$231,240
20166402,270$302,805
20176312,235$396,001
20187142,470$375,081
20197542,431$632,261
20207772,524$743,643
20218402,394$950,207
20229052,522$1,120,351
20231,0072,646$1,564,774
20241,0342,749$1,889,702

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth327372$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more441520$57
17000Destruction of precancer skin growth, 1 growth8131,029$36
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more491542$34
17003Destruction of precancer skin growth, 2-14 growths5922,837$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa312,268$664,934
Cosentyx Sensoready (2 Pens)Secukinumab371,036$379,505
OtezlaApremilast531,590$248,333
Humira(Cf) PenAdalimumab25700$172,483
Dupixent PenDupilumab22574$80,555

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$150ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian Christopher Thomas, MD?

Tedicare shows public-source Medicare data for Brian Christopher Thomas, MD (NPI 1508837394), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Christopher Thomas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Christopher Thomas, MD?

Brian Christopher Thomas, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1346855327) in the available physician profile data.

Does Brian Christopher Thomas, MD have Open Payments data?

Brian Christopher Thomas, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.